7-116769637-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_000245.4(MET):​c.2584-8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0015 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

MET
NM_000245.4 splice_region, intron

Scores

2
Splicing: ADA: 0.0001014
2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.358

Publications

0 publications found
Variant links:
Genes affected
MET (HGNC:7029): (MET proto-oncogene, receptor tyrosine kinase) This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers. [provided by RefSeq, May 2016]
MET Gene-Disease associations (from GenCC):
  • hereditary papillary renal cell carcinoma
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • papillary renal cell carcinoma
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen
  • autosomal recessive nonsyndromic hearing loss 97
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • osteofibrous dysplasia
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • arthrogryposis, distal, IIa 11
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 7-116769637-C-T is Benign according to our data. Variant chr7-116769637-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 517049.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000245.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MET
NM_000245.4
MANE Select
c.2584-8C>T
splice_region intron
N/ANP_000236.2
MET
NM_001127500.3
c.2638-8C>T
splice_region intron
N/ANP_001120972.1
MET
NM_001324402.2
c.1294-8C>T
splice_region intron
N/ANP_001311331.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MET
ENST00000397752.8
TSL:1 MANE Select
c.2584-8C>T
splice_region intron
N/AENSP00000380860.3
MET
ENST00000318493.11
TSL:1
c.2638-8C>T
splice_region intron
N/AENSP00000317272.6
MET
ENST00000436117.3
TSL:1
n.*189-8C>T
splice_region intron
N/AENSP00000410980.2

Frequencies

GnomAD3 genomes
AF:
0.00105
AC:
141
AN:
133886
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000448
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000890
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00767
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000855
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00883
AC:
1811
AN:
205052
AF XY:
0.00898
show subpopulations
Gnomad AFR exome
AF:
0.00346
Gnomad AMR exome
AF:
0.0146
Gnomad ASJ exome
AF:
0.0106
Gnomad EAS exome
AF:
0.00867
Gnomad FIN exome
AF:
0.00123
Gnomad NFE exome
AF:
0.00599
Gnomad OTH exome
AF:
0.0102
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00150
AC:
2095
AN:
1396732
Hom.:
0
Cov.:
35
AF XY:
0.00153
AC XY:
1061
AN XY:
693700
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00629
AC:
190
AN:
30204
American (AMR)
AF:
0.0142
AC:
502
AN:
35406
Ashkenazi Jewish (ASJ)
AF:
0.00353
AC:
81
AN:
22964
East Asian (EAS)
AF:
0.000238
AC:
9
AN:
37744
South Asian (SAS)
AF:
0.00731
AC:
555
AN:
75970
European-Finnish (FIN)
AF:
0.000542
AC:
27
AN:
49820
Middle Eastern (MID)
AF:
0.00187
AC:
10
AN:
5360
European-Non Finnish (NFE)
AF:
0.000577
AC:
624
AN:
1082256
Other (OTH)
AF:
0.00170
AC:
97
AN:
57008
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.299
Heterozygous variant carriers
0
144
289
433
578
722
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00107
AC:
143
AN:
133956
Hom.:
0
Cov.:
31
AF XY:
0.00113
AC XY:
73
AN XY:
64658
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000502
AC:
18
AN:
35826
American (AMR)
AF:
0.000888
AC:
12
AN:
13506
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3012
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4662
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4224
European-Finnish (FIN)
AF:
0.00767
AC:
60
AN:
7824
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
256
European-Non Finnish (NFE)
AF:
0.000855
AC:
53
AN:
61974
Other (OTH)
AF:
0.00
AC:
0
AN:
1860
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.299
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00106
Hom.:
2

ClinVar

ClinVar submissions as Germline

Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
-
-
1
Papillary renal cell carcinoma type 1 (1)
-
-
1
Renal cell carcinoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.089
DANN
Benign
0.39
PhyloP100
-0.36
PromoterAI
-0.029
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00010
dbscSNV1_RF
Benign
0.046
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs370833501; hg19: chr7-116409691; API